-
EP3573994
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3573994
| EP3573994 - CYSTEAMINE PRODRUGS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 17.02.2023 Database last updated on 29.07.2024 | |
| Former | Request for examination was made Status updated on 01.11.2019 | ||
| Former | The international publication has been made Status updated on 04.08.2018 | Most recent event Tooltip | 06.07.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Children's Hospital Center, d/b/a Cincinnati Children's Hospital Medical Center 3333 Burnet Avenue Cincinnati, OH 45229-3039 / US | [2022/22] |
| Former [2019/49] | For all designated states Adare Pharmaceuticals, Inc. 1200 Lenox Drive, Suite 100 Lawrenceville, NJ 08648 / US | Inventor(s) | 01 /
PERRETT, Stephen c/o ADARE PHARMACEUTICALS INC. 1200 Lenox Drive Suite 100 Lawrenceville New Jersey 08648 / US | [2019/49] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2019/49] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 18745367.5 | 25.01.2018 | [2019/49] | WO2018US15218 | Priority number, date | US201762450431P | 25.01.2017 Original published format: US 201762450431 P | US201762466589P | 03.03.2017 Original published format: US 201762466589 P | [2019/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018140594 | Date: | 02.08.2018 | Language: | EN | [2018/31] | Type: | A1 Application with search report | No.: | EP3573994 | Date: | 04.12.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2018 takes the place of the publication of the European patent application. | [2019/49] | Search report(s) | International search report - published on: | US | 02.08.2018 | (Supplementary) European search report - dispatched on: | EP | 13.10.2020 | Classification | IPC: | C07C329/06, C07C323/25, A61P35/00, A61P25/00, A61P1/00, A61K31/325, A61K31/27 | [2020/46] | CPC: |
C07C329/06 (EP);
A61K31/25 (US);
A61K31/573 (US);
A61P1/00 (EP);
C07C323/25 (EP);
C07C323/60 (US)
|
| Former IPC [2019/49] | C07H5/10, C07H15/00, C07H17/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/49] | Title | German: | CYSTEAMIN-PRODRUGS | [2019/49] | English: | CYSTEAMINE PRODRUGS | [2019/49] | French: | PROMÉDICAMENTS DE CYSTÉAMINE | [2019/49] | Entry into regional phase | 13.08.2019 | National basic fee paid | 13.08.2019 | Search fee paid | 13.08.2019 | Designation fee(s) paid | 13.08.2019 | Examination fee paid | Examination procedure | 13.08.2019 | Examination requested [2019/49] | 01.09.2021 | Amendment by applicant (claims and/or description) | 20.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 26.06.2023 | Reply to a communication from the examining division | 14.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 05.07.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 01.09.2021 | Request for further processing filed | 01.09.2021 | Full payment received (date of receipt of payment) Request granted | 17.09.2021 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 01.09.2021 | Request for further processing filed | 01.09.2021 | Full payment received (date of receipt of payment) Request granted | 17.09.2021 | Decision despatched | Fees paid | Renewal fee | 27.01.2020 | Renewal fee patent year 03 | 27.01.2021 | Renewal fee patent year 04 | 27.01.2022 | Renewal fee patent year 05 | 27.01.2023 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.01.2024 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]US2017081279 (NGUYEN MARK QUANG [US]) [XP] 1-15* paragraphs [0110] , [0129] , [0134] , [0147] - [0199] *; | [XI] - FROST LISA ET AL, "Synthesis of diacylated [gamma]-glutamyl-cysteamine prodrugs, andin vitroevaluation of their cytotoxicity and intracellular delivery of cysteamine", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, (20151224), vol. 109, doi:10.1016/J.EJMECH.2015.12.027, ISSN 0223-5234, pages 206 - 215, XP029399586 [X] 1,2,5-7,9,12-15 * page 207, scheme 1: cysteine-cysteamine dimer * * page 208; figure 1; compounds 1a-c, 2a-c, 3a-c, 4 * * page 209, scheme 3, compounds 8a-c, 9a-c, 10a-c, 11a-c * * page 211, conclusion * * abstract * [I] 1-15 DOI: http://dx.doi.org/10.1016/j.ejmech.2015.12.027 | [XI] - ROBERTS J C ET AL, "THIAZOLIDINE PRODRUGS OF CYSTEAMINE AND CYSTEINE AS RADIOPROTECTIVEAGENTS", RADIATION RESEARCH, ACADEMIC PRESS INC, US, (1995), vol. 143, no. 2, ISSN 0033-7587, pages 203 - 213, XP001029418 [X] 1-5,12-15 * page 204; figure 1; compounds RibCyst, GlcCyst * * abstract * * page 212, column left, paragraph last * [I] 1-15 | International search | [A]US6340746 (ROBERTS JEANNETTE C [US], et al) [A] 1-3 * Entire Document *; | [A]US2009048154 (CHAN BILL PIU [CN], et al) [A] 1-3* Entire Document *; | [A]US2014322315 (DOHIL RANJAN [US], et al) [A] 1-3 * Entire Document *; | [X]US2016102052 (O'NEIL DEBORAH [GB], et al) [X] 1-3 * para [0039] * |